Purdue Pharma

May 10, 2007 -- "Today's criminal convictions confirm a tragic story - tragic for many patients, their families and the company.

"Purdue Pharma knowingly spread dangerous disinformation about OxyContin, falsely assuring doctors and patients that this powerful pain reliever was less addictive than similar medications. The company's misrepresentations led to addiction and abuse in Connecticut and nationwide.    » read more »

Wisconsin, 25 Other States and D.C. Address Concerns with Purdue Pharma’s Pain Drug – OxyContin

May 8, 2007 -- MADISON - Wisconsin Attorney General J.B. Van Hollen announced that Wisconsin and 25 other states, as well as the District of Columbia, filed settlements with Purdue Pharma over marketing practices regarding the narcotic pain medication OxyContin.

The settlement provides for a monetary payment by Purdue to the states in the amount of $19,500,000. Wisconsin’s share of the settlement is $719,500.    » read more »

May 08, 2007 -- SEATTLE – Washington Attorney General Rob McKenna today announced a $19.5 million multi-state settlement with Purdue Pharma. Washington will receive $719,500 from the agreement, which resolves allegations the company aggressively marketed its painkiller OxyContin to doctors while downplaying the risk of addiction.    » read more »

States Reach $19.5 Million Civil Settlement with Purdue Pharma over OxyContin Marketing Practices; Virginia to Receive Nearly $1 Million

May 8, 2007 -- RICHMOND – Virginia Attorney General Bob McDonnell today announced that Virginia, along with 25 other states and the District of Columbia, has reached a civil settlement with Purdue Pharma L.P. and associated companies regarding the promotion and marketing of the pain medication OxyContin.    » read more »

Settlement with Vermont Will Reach almost $950,000

May 8, 2007 - Vermont and 25 other states, as well as the District of Columbia, filed Consent Judgments regarding the narcotic pain medication OxyContin. The settlement resolves concerns that Purdue Pharma, the manufacturer of OxyContin, had engaged in extensive off-label marketing of this time-released, Schedule II opioid. Pharmaceutical companies are generally not allowed to market their prescription drugs for uses that are not approved by the U.S. Food and Drug Administration.    » read more »

May 8, 2007 -- HARRISBURG - Pennsylvania Attorney General Tom Corbett today announced that Pennsylvania, along with 25 other states and the District of Columbia, have reached a $19.5 million settlement with drug-maker Purdue Pharma concerning allegations of deceptive marketing and promotion of OxyContin - a powerful and often abused pain medication.    » read more »

May 8, 2007 --

Settles concerns about off-label marketing of narcotic pain medication OxyContin

Oregon Attorney General Hardy Myers today filed a stipulated general judgment in Marion County Circuit Court with Purdue Pharma L.P. of Stamford, Connecticut resolving allegations by the Oregon Department of Justice and 25 other states and the District of Columbia that the company engaged in extensive off-label marketing of the narcotic pain medication OxyContin. Named in the judgment were Purdue Pharma L.P. and Purdue Pharma, Inc., doing business as Purdue Frederick Company.    » read more »

26 States and D.C. Address Concerns with Purdue Pharma’s Pain Drug – OxyContin

May 08, 2007 -- COLUMBUS - Ohio and 25 other states, as well as the District of Columbia, filed settlements with Purdue Pharma Inc., regarding the narcotic pain medication OxyContin®.    » read more »

AG Cooper and 26 other state AGs reach settlement with Purdue Pharma for pain drug OxyContin

May 8, 2007 -- Raleigh: A major drug company will pay North Carolina and 26 other states $19.5 million for marketing its pain drug OxyContin for off-label use and for failing to adequately disclose the drug’s potential for abuse and addiction, Attorney General Roy Cooper said today.    » read more »

May 8, 2007 -- HELENA – Montana Attorney General Mike McGrath said today that Montana and 25 other states have reached a settlement with drug company Purdue Pharma regarding the narcotic pain medication OxyContin.

The multi-state agreement resolves concerns that Purdue had engaged in extensive "off-label" marketing of OxyContin, promoting the drug for purposes other than its approved uses. The settling states also contended that Purdue failed to disclose the drug's potential for abuse and addiction.    » read more »

Massachusetts’ Share of $19.5 Million Settlement to Be Used to Combat Youth Prescription Drug Abuse

May 8, 2007 -- BOSTON - Today, Massachusetts Attorney General Martha Coakley's Office reached a settlement with Purdue Pharma, the maker of the narcotic pain medication OxyContin. Massachusetts was a leader of the multi-state investigation concerning Purdue Pharma’s extensive off-label marketing of OxyContin. The investigation also uncovered that Purdue Pharma failed to disclose abuse and addiction risks associated with the drug.    » read more »

May 8, 2007 -- (Lincoln, NE) -- Nebraska Attorney General Jon Bruning today filed a $719,500 settlement in Lancaster County District Court with Purdue Pharma (Purdue) regarding its advertising practices for the narcotic pain medication, OxyContin.    » read more »

Company to Change Practices in Marketing of Oxycontin

May 8, 2007 -- Maryland Attorney General Douglas F. Gansler announced today that his Consumer Protection Division, together with the offices of Attorneys General from 26 other states, has entered into a settlement of Consumer Protection Act claims against Purdue Pharma (“Purdue”) regarding the narcotic pain medication OxyContin, a time-released narcotic drug approved for the treatment of moderate to severe pain over an extended period of time.    » read more »

May 08, 2007 -- Kentucky Attorney General Greg Stumbo today announced a settlement with pharmaceutical maker Purdue Pharma regarding the narcotic pain medication OxyContin. The settlement resolves concerns that Purdue Pharma engaged in extensive off-label marketing of OxyContin, a time-released, Schedule II opioid used for pain management of moderate to severe pain over an extended period of time, and that Purdue Pharma failed to adequately disclose abuse and diversion risks associated with the drug in violation of Kentucky’s consumer protection statutes.    » read more »

May 8, 2007 -- Springfield – Illinois Attorney General Lisa Madigan, along with 26 other attorneys general, today filed a lawsuit and entered into a settlement agreement with Purdue Pharma, L.P., requiring the pharmaceutical company to significantly alter and restrict its practices in promoting the drug, OxyContin, and to pay $19.5 million to the states involved.    » read more »